Effects of Alveolar Recruitment Strategies on Arterial Oxygenation and Postoperative Inflammatory Response During Laparoscopic Bariatric Surgery: A Randomised Control Trial.
NCT ID: NCT05960071
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-11-05
2023-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients and methods: a prospective randomized study involved 60 adult obese patients (18-65 years), with American Society of Anaesthesiologists physical Status classification 1-2, enrolled in 2 groups; Group S: received protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and steady PEEP (10) cm H2o in between RM till end of surgery. Group D: received protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and decreasing PEEP (15, 10, and 5) cm H20 (10 minutes for each level) in between RM till end of surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Recruitment Manouever on Oxygenation, Oxygen Reserve Index and Postoperative Pulmonary Complications
NCT05705245
Clinical Significance of Alveolar Recruitment Maneuver During Bariatric Surgery
NCT02592226
Effect of Intraoperative Dynamic Compliance Guided Individualized Positive End-expiratory Pressure on Postoperative Atelectasis After Laparoscopic Bariatric Surgery
NCT04169607
Driving Pressure Guided Ventilation Versus Conventional Lung Protective Strategy in Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery
NCT04861168
Postoperative Hypoxemia in Obese Patients
NCT06589011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* sixty adult obese patients (body mass index more than 35 kg/m2), of both sexes, aged from 18-65 years old, with American Society of Anaesthesiologists physical Status classification scores of 1-2, scheduled for laparoscopic bariatric procedures. Exclusion criteria were patients refusal, history of significant pulmonary disease (obstructive or restrictive), previous pneumothorax, significant cardiac dysfunction (arrhythmias ± unstable haemodynamics, left ventricular ejection fraction \< 40%), difficult intubation as well as those suffering from significant hepatic or renal impairment. Furthermore, patients developed episodes of hemodynamic instability (like desaturation (Sp02\< 90 %) or mean blood pressure (MAP) \< 60 mmHg) during recruitment manoeuvre were omitted from the study.
* Subjects were randomly assigned -via closed envelopes technique opened immediately before induction- into 2 equal groups (n=30 each) to receive 1 of the following ventilatory regimens:
* Group S: patients received protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and steady PEEP (10) cm H2o in between RM till end of surgery.
* Group D: patients received protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and decreasing PEEP (15, 10, and 5) cm H20 (10 minutes for each level) in between RM till end of surgery.
* Anaesthesia was induced with lidocaine (1mg/kg) followed by (1.5 - 2 mg/kg) propofol (ideal body weight) and (1-1.5 μg/kg) fentanyl. Endotracheal intubation was accomplished with rocuronium (1mg/kg) and a suitable sized tube (8.0 ID). Anaesthesia was maintained with sevoflurane (1-2 %) with (50 %) oxygen in air. Neuromuscular block was continued with rocuronium boluses monitored by train-of four along with additional doses of opioids given as required to achieve a suitable clinical depth of anaesthesia. Precise fluid replacement was administrated consistent with the standard administration guidelines during anaesthesia.
* Patients were ventilated using Datex-Ohmeda Aestiva/5 (Madison, WI) anaesthesia machine, (volume controlled mode) with lung protective strategy using a tidal volume of 6- 8 ml/kg ideal body weight, (5-10 cm H20) PEEP and 50 % O2 in air adjusted to reach Spo2 ≥ 95 %. The respiratory rate was adjusted to keep end - tidal Co2 level between (35 -45 mmHg), and inspiratory to expiratory times at a ratio 1:2.
* Measurements
1. Hemodynamic parameters: HR and MAP.
2. Respiratory mechanics: Peak airway pressure (Paw-peak) and Plateau pressure (Paw-plat).
3. Oxygenation parameters: Partial arterial tension of oxygen (PaO2), PaO2/FiO2 ratio and oxygen saturation (SpO2).
All the previous measurements were recorded at the following time points: T0 (baseline value on room air), T5 (5 minutes after pneumoperitoneum), T30 (30 minutes after first RM), T6o (60 minutes after first RM), T90 (90 minutes after first RM), TE (20 minutes after the end of surgery on nasal cannula 3 L /min). Additional arterial blood gases analysis was performed in the PACU after 30 mins and 1 hr postoperatively.
4. Serum interleukins (IL)-6 and (IL)-8, using enzyme-linked immunosorbent assay (ELISA) (Biosource, Biosite, Germany) in (pg/ml) were measured as baseline preoperative value and after 24 hr postoperatively. Validation of methods and degrees of concentrations was done following to the accompanied instructions.
5. Postoperative pulmonary and non-pulmonary complication - (if any) - were assessed and reported in the PACU.
6. Other variables like: duration of anaesthesia, duration of surgery, pneumoperitoneum time, number of patients needed vasopressors, length of ICU stay and hospital stay.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group S
patients received protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and steady PEEP (10) cm H2O in between RM till end of surgery.
protective lung strategy with recruitment manoeuvre (RM) - steady PEEP
protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and steady PEEP (10) cm H2o in between RM till end of surgery.
Group D
patients received protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and decreasing PEEP (15, 10, and 5) cm H20 (10 minutes for each level) in between RM till end of surgery.
protective lung strategy with recruitment manoeuvre (RM) - decreasing PEEP
protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and decreasing PEEP (15, 10, and 5) cm H20 (10 minutes for each level) in between RM till end of surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
protective lung strategy with recruitment manoeuvre (RM) - steady PEEP
protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and steady PEEP (10) cm H2o in between RM till end of surgery.
protective lung strategy with recruitment manoeuvre (RM) - decreasing PEEP
protective lung strategy with recruitment manoeuvre (RM) every 30 minutes and decreasing PEEP (15, 10, and 5) cm H20 (10 minutes for each level) in between RM till end of surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of significant pulmonary disease (obstructive or restrictive),
* previous pneumothorax,
* significant cardiac dysfunction (arrhythmias ± unstable haemodynamics
* left ventricular ejection fraction \< 40%)
* difficult intubation
* significant hepatic or renal impairment.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alexandria University Faculty of Medicin
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0305904
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.